Spanish study of 78 RA pts shows that Rituximab (#RTX) use was associated with a lower risk of functional respiratory decline compared with non-exposure (HR 0.51; 95% CI 0.31, 0.85). Higher w/ UIP; lower with steroids, disease activity & lower duration https://t.co/jyUXbmQDYl